Endocan Corp
Thermic Sciences International develops and sells hemp based products. The company offers hemp formulation-based health and wellness solutions, as well as cosmeceuticals, nutraceuticals, and food brands. It also provides over the counter products for hair and skin include Hempery miracle oil, a skin care solution; Hemp milk body wash, a creamy soap; Hemp lotion bars for moisturizing hands and bod… Read more
Endocan Corp (ENDO) - Total Assets
Latest total assets as of March 2013: $59.00 USD
Based on the latest financial reports, Endocan Corp (ENDO) holds total assets worth $59.00 USD as of March 2013.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Endocan Corp - Total Assets Trend (2000–2012)
This chart illustrates how Endocan Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Endocan Corp - Asset Composition Analysis
Current Asset Composition (December 2012)
Endocan Corp's total assets of $59.00 consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 100.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2012)
This chart illustrates how Endocan Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Endocan Corp's current assets represent 100.0% of total assets in 2012, unchanged from 100.0% in 2000.
- Cash Position: Cash and equivalents constituted 100.0% of total assets in 2012, the same as 100.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Endocan Corp Competitors by Total Assets
Key competitors of Endocan Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Chinyang Hold
KO:100250
|
Korea | ₩686.19 Billion |
|
DL Holdings Co Ltd Preferred
KO:000215
|
Korea | ₩12.05 Trillion |
|
Norooholdings
KO:000320
|
Korea | ₩1.26 Trillion |
|
Noroo Holdings Co Ltd
KO:000325
|
Korea | ₩1.26 Trillion |
|
Samhwa Paint
KO:000390
|
Korea | ₩617.09 Billion |
|
Chongqing Sanxia Paints Co Ltd
SHE:000565
|
China | CN¥1.65 Billion |
|
Hengyi Petrochemical Co Ltd
SHE:000703
|
China | CN¥111.51 Billion |
|
Guangdong Xinhui Meida Nylon Co Ltd
SHE:000782
|
China | CN¥3.04 Billion |
Endocan Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Endocan Corp generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Endocan Corp is currently not profitable relative to its asset base.
Endocan Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.00 | 0.04 | 0.40 |
| Quick Ratio | 0.00 | 0.04 | 0.37 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.49 Million | $ -1.14 Million | $ -636.77K |
Endocan Corp - Advanced Valuation Insights
This section examines the relationship between Endocan Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 12.18 |
| Latest Market Cap to Assets Ratio | 9.16 |
| Asset Growth Rate (YoY) | -99.9% |
| Total Assets | $359.00 |
| Market Capitalization | $3.29K USD |
Valuation Analysis
Premium Asset Valuation: The market values Endocan Corp's assets at a significant premium ( 9.16x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Endocan Corp's assets decreased by 99.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Endocan Corp (2000–2012)
The table below shows the annual total assets of Endocan Corp from 2000 to 2012.
| Year | Total Assets | Change |
|---|---|---|
| 2012-12-31 | $359.00 | -99.94% |
| 2010-12-31 | $571.26K | +6190.72% |
| 2009-12-31 | $9.08K | -99.03% |
| 2008-12-31 | $933.38K | -38.69% |
| 2007-12-31 | $1.52 Million | +214.96% |
| 2006-12-31 | $483.35K | +735.14% |
| 2005-12-31 | $57.88K | +38.53% |
| 2004-12-31 | $41.78K | +9919.18% |
| 2000-12-31 | $417.00 | -- |